Bevacizumab and Sunitinib in Treating Patients With Solid Tumors

Clinical trial NCT00357318 · COMPLETED

Trial details

NCT number: NCT00357318
Sponsor: National Cancer Institute (NCI)
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Unspecified Adult Solid Tumor, Protocol Specific

Start date: 2006-06-01
Primary completion: 2012-07-01
Enrollment: 60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.